Overall (n = 240) | High GNRI (≥90, n = 103) | Low GNRI (< 90, n = 137) | P | |
---|---|---|---|---|
Percutaneous drainage | 126 (52.5%) | 44 (42.7) | 82 (59.9) | 0.009a |
Operation | 4 (1.7) | 1 (1.0) | 3 (2.2) | 0.466b |
Hospital length of stay, days | 17.6 ± 9.2 | 18.3 ± 10.3 | 17.0 ± 8.2 | 0.275** |
Hospitalization expenses, *104 CNY | 3.2 ± 2.5 | 2.9 ± 2.4 | 3.5 ± 2.5 | 0.035 |
Adverse outcomes | 75 (31.3) | 20 (19.4) | 55 (40.0) | 0.001a |
Mortality | 21 (8.6) | 2 (2.0) | 19 (13.4) | 0.002a |
Metastatic infection | 33 (13.6) | 8 (8.2) | 25 (17.7) | 0.05a |
Acute renal failure | 9 (3.9) | 2 (2,0) | 7 (5.2) | 0.220b |
Acute hepatic failure | 10 (4.3) | 1 (1.0) | 9 (6.8) | 0.036b |
Acute respiratory failure | 11 (4.7) | 1 (1.0) | 10 (7.4) | 0.024b |
Acute myocardial infarction | 8 (3.4) | 3 (3.1) | 5 (3.7) | 0.783b |
UGI bleeding | 18 (7.8) | 2 (2.1) | 16 (11.9) | 0.006a |
empyema | 38 (15.9) | 11 (10.2) | 27 (20.1) | 0.047a |
Septic shock | 20 (8.2) | 7 (6.1) | 13 (9.8) | 0.346a |